In contrast, in the STAMEDE clinical trial, the surgical group showed a trend of insignificant reduction in eGFR compared with the medical group after 5 years follow-up (− 1.1% in medical group, − 7.7% in gastric bypass group, − 6.2% in sleeve gastrectomy group).
← all excerpts
The Effects of Bariatric Surgery on Renal, Neurological, and Ophthalmic Complications in Patients with Type 2 Diabetes: the Taiwan Diabesity Study.
1
—
—